News
As GLP-1-based drugs like semaglutide gain popularity, new insights highlight how gut health, diet, protein, and sleep can ...
Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
GLP-1 RAs used by adults with type 2 diabetes and obesity is linked to lower risk for dementia, stroke, and mortality vs ...
People with type 2 diabetes were more likely to suffer from gastroesophageal reflux disease (GERD) if they were prescribed a ...
Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Researchers at St. Louis University followed 110 men with obesity, many with type 2 diabetes, who were being treated with GLP ...
5d
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersSAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...
Overall, people should adopt a well-balanced, nutrient-dense diet to compliment their GLP-1 drug use, experts say. Avoid ...
There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results